Procedure

United States Architecture, Engineering and Construction (AEC) Firm Policies, Procedures & Benefits Report 2023 - ResearchAndMarkets.com

Retrieved on: 
Monday, April 8, 2024
Engineering, Architecture, Construction & Property, Manufacturing, AEC, Education, Procedure, HR, Policy, Management

The "2023 Policies, Procedures & Benefits Report of AEC Firms" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "2023 Policies, Procedures & Benefits Report of AEC Firms" report has been added to ResearchAndMarkets.com's offering.
  • The results of this study will help you benchmark your AEC firm in all areas related to benefits and compensation.
  • The 2023 Policies, Procedures & Benefits Survey Report of AEC Firms provides you with industry statistics on policies and procedures, so you can support your policy decisions with hard data.
  • The data presented in the 2023 Policies, Procedures & Benefits Survey Report is broken down by firm type, size, region, and other important factors, so you can make accurate comparisons between your firm and others.

GuidePoint Security Helps Organizations Address Data Privacy Requirements with Portfolio of Services

Retrieved on: 
Thursday, March 21, 2024
Data Management, Security, Technology, Software, Networks, Internet, Metric, Organization, Exercise, Digital, Information, Risk, U.S. state, GDPR, DSAR, Process, PET, Bill of Rights, IPO, GPC, Privacy, NIST, Architecture, HIPAA, Do Not Track, FERPA, Procedure, ISO, Federal, Legislation, Guidepoint, Online shopping

GuidePoint Security , a cybersecurity solutions leader enabling organizations to make smarter decisions and minimize risk, today announced the availability of its Data Privacy services, which are designed to help customers take control of their privacy operations.

Key Points: 
  • GuidePoint Security , a cybersecurity solutions leader enabling organizations to make smarter decisions and minimize risk, today announced the availability of its Data Privacy services, which are designed to help customers take control of their privacy operations.
  • These new data privacy laws will require companies to be accountable and to evaluate and ensure data protection addendums in their processes.
  • GuidePoint’s Data Privacy Services are tailored to meet an organization and its data privacy program at its current maturity level.
  • “We have developed a broad portfolio of data privacy services to meet a customer at their current maturity level,” said Scott Griswold, Practice Director - Governance Services, GuidePoint Security.

Global Pediatric Interventional Cardiology Market Forecast 2024-2030: PIC Market Forecast for 6.36% CAGR Between 2024 to 2030 - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 29, 2024
General Health, Health, Cardiology, Heart, Incidence, Procedure, Catheter, Birth defect, Investment, Physician, Moyamoya disease, Congenital heart defect, Projection, VSD, Angioplasty, Prevalence, CHD, Coronary thrombosis, Atherectomy, Patient, Stent, Ventricular septal defect, CDC, Catheter ablation, Research, Medical imaging

The Pediatric Interventional Cardiology Market is forecasted to reach US$ 3.91 Billion through 2030.

Key Points: 
  • The Pediatric Interventional Cardiology Market is forecasted to reach US$ 3.91 Billion through 2030.
  • The pediatric interventional cardiology market proportion is expanding swiftly, driven by the rising prevalence of cardiac disorders in children and technological advancements.
  • The Stents segment is anticipated to dominate the global pediatric interventional cardiology market throughout the forecast period.
  • The comprehensive infrastructure of hospitals, coupled with their ability to provide diverse pediatric cardiology services, positions them as key contributors to the growth and development of the Pediatric Interventional Cardiology market.

Global Clear Aligner Market Analysis and Forecast to 2029: Compound Annual Growth of 22% Forecast During 2024-2029, Driven by Growing Patient Population Suffering from Malocclusions - ResearchAndMarkets.com

Retrieved on: 
Monday, February 19, 2024
Dental, Health, Incidence, Codd-neck bottle, Procedure, Malocclusion, Dentist, Growth, Treatment, Dentistry, Orthodontics, Urbanization, Dental care, Stand-alone, Prevalence, CAD, GNI, COVID-19, Age, Platform, Disease, Ageing, Insurance

The global clear aligner market was valued at US$5.56 billion in 2023.

Key Points: 
  • The global clear aligner market was valued at US$5.56 billion in 2023.
  • An increase in the incidence of periodontitis would support the growth of the clear aligner market in Europe.
  • The rising prevalence of malocclusion cases is positively affecting the demand for the clear aligner and hence, boosting the market growth.
  • Thus, the growing dental tourism is expected to stimulate the demand for clear aligners in the coming years.

Questions and answers on the European Union framework for (traditional) herbal medicinal products, including those from a ‘non-European’ tradition

Retrieved on: 
Sunday, March 10, 2024
Well, DER, Fungus, Capsule, TUR, Interest, Animal, Part, Exercise, Database, Viral, Hepatitis, Powder, Collection, Directive, Union, Nutrient, DSM-IV codes, Volume, CTD, Legislation, Literature, Fermentation, Diabetes, Pharmacopoeia, Inhalation, Committee, Monograph, NTA, WEU, DCP, AIDS, See, Mineral, Marketing, Safety, Plant, MRA, Autoimmunity, Directive 2001/83/EC, GMP, Documentation, Seed, Heart failure, Distillation, CHMP, MRP, European Medicines Agency, Guideline, Disorder, Mutual, Convention, State, Tablet, Community, Clinical trial, Rapporteur, European Commission, Woman, Medication package insert, Vitamin, Quality, Authority, GACP, SAWP, Pharmacovigilance, Civil service commission, HMPS, Science, Health, Bibliography, Section 4, Infection, Kampo, Commission, Abbreviation, Pathology, Prescription, Human, Medication, Reproduction, EMA, NCA, Chapter One, EDQM, TAM, European Pharmacopoeia, European Economic Area, Food, Regulation (European Union), COM, TCM, Administration, Mutual recognition, Procedure, Medicine, Herbal, Answer, Q&A, HIV, EudraLex, Cancer, Public, Medicinal plants

1

Key Points: 
    • 1
      Committee on Herbal Medicinal Products (HMPC)

      Questions & Answers on the European Union framework
      for (traditional) herbal medicinal products, including those
      from a ?non-European? tradition

      Table of Content
      1.

    • European Pharmacopoeia

      SAWP

      Scientific Advice Working Party

      SmPC

      Summary of Product Characteristics

      THMP

      Traditional Herbal Medicinal Product

      TUR

      Traditional Use Registration

      WEU

      Well-Established Use

      Questions & Answers on the European Union framework for (traditional) herbal
      medicinal products, including those from a ?non-European? tradition
      EMA/HMPC/402684/2013 Rev.

    • Terminology of herbal medicinal products (Q&A 1-4)

      Question 1
      What are herbal substances, herbal preparations, and herbal medicinal products?

    • Questions & Answers on the European Union framework for (traditional) herbal
      medicinal products, including those from a ?non-European? tradition
      EMA/HMPC/402684/2013 Rev.
    • Question 4
      Are food supplements regulated under the European Union (EU) pharmaceutical legislation
      for (traditional) herbal medicinal products ((T)HMPs)?
    • Questions & Answers on the European Union framework for (traditional) herbal
      medicinal products, including those from a ?non-European? tradition
      EMA/HMPC/402684/2013 Rev.
    • Regulation of herbal medicinal products in the European Union (Q&A 511)

      Question 5
      Where to find the pharmaceutical legislation and dossier requirements for herbal medicinal
      products (HMPs), including traditional herbal medicinal products (THMPs), in the European
      Union (EU)?

    • Questions & Answers on the European Union framework for (traditional) herbal
      medicinal products, including those from a ?non-European? tradition
      EMA/HMPC/402684/2013 Rev.
    • These countries have,
      through the EEA agreement, adopted the complete Union acquis on medicinal products and are
      consequently parties to the Union procedures.
    • Questions & Answers on the European Union framework for (traditional) herbal
      medicinal products, including those from a ?non-European? tradition
      EMA/HMPC/402684/2013 Rev.
    • Questions & Answers on the European Union framework for (traditional) herbal
      medicinal products, including those from a ?non-European? tradition
      EMA/HMPC/402684/2013 Rev.
    • Questions & Answers on the European Union framework for (traditional) herbal
      medicinal products, including those from a ?non-European? tradition
      EMA/HMPC/402684/2013 Rev.
    • Questions & Answers on the European Union framework for (traditional) herbal
      medicinal products, including those from a ?non-European? tradition
      EMA/HMPC/402684/2013 Rev.
    • Specific provisions for traditional herbal medicinal products (Q&A 1221)

      Question 12
      Which indications can be granted for traditional herbal medicinal products (THMPs)?

    • Questions & Answers on the European Union framework for (traditional) herbal
      medicinal products, including those from a ?non-European? tradition
      EMA/HMPC/402684/2013 Rev.
    • Nov. 2023
      Answer 17

      Questions & Answers on the European Union framework for (traditional) herbal
      medicinal products, including those from a ?non-European? tradition
      EMA/HMPC/402684/2013 Rev.

    • Questions & Answers on the European Union framework for (traditional) herbal
      medicinal products, including those from a ?non-European? tradition
      EMA/HMPC/402684/2013 Rev.
    • Question 29
      Does the Committee on Herbal Medicinal Products (HMPC) hold a specific database on
      (registered) authorised (traditional) herbal medicinal products ((T)HMPs)?
    • Discussion with Member States intended to be

      Questions & Answers on the European Union framework for (traditional) herbal
      medicinal products, including those from a ?non-European? tradition
      EMA/HMPC/402684/2013 Rev.

    • Questions & Answers on the European Union framework for (traditional) herbal
      medicinal products, including those from a ?non-European? tradition
      EMA/HMPC/402684/2013 Rev.

CH4 Global welcomes FDA move on animal feed additives

Retrieved on: 
Thursday, February 8, 2024
Agriculture, Methane, Policy, Cattle, FDA, Food, Climate change, Innovation, Congress, Farmer, Animal, Legislation, Procedure, Water, Habit

HENDERSON, Nev., Feb. 8, 2024 /PRNewswire/ -- CH4 Global today issued the following statement regarding the announcement by the U.S. Food and Drug Administration (FDA) that it plans to withdraw a policy that caused multi-year approval delays for certain animal-feed additives that can produce beneficial effects via animal digestive systems:

Key Points: 
  • This vital step by the FDA demonstrates a commitment to modernizing regulations around animal food additives, marking a major milestone for U.S. agriculture that brings our company closer to being able to commercialize our innovative feed additive in the United States.
  • The FDA's decision to encourage early engagement with companies developing novel animal foods is a positive move for farmers, consumers, and efforts to mitigate climate change.
  • In light of this positive regulatory development, CH4 Global continues to call on Congress to provide additional clarity by passing the Innovative FEED Act without delay.
  • Passage of the Innovative FEED Act will establish a clear and transparent regulatory process, not only supporting companies like CH4 Global in bringing innovative products to market, but also bolstering the global competitiveness of U.S. farmers while reducing regulations in line with other countries.

U.S Architecture, Engineering, Construction (AEC) Firms Gain Strategic Edge with 2023 Future Owners Bundle Report - ResearchAndMarkets.com

Retrieved on: 
Monday, January 22, 2024
Engineering, Architecture, Construction & Property, Manufacturing, Culture, Procedure, Partner, Benchmarking, AEC, Growth, Management

The "2023 Future Owners Bundle Report of U.S Architecture, Engineering, Construction (AEC) Firms" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "2023 Future Owners Bundle Report of U.S Architecture, Engineering, Construction (AEC) Firms" report has been added to ResearchAndMarkets.com's offering.
  • A comprehensive research suite, titled the "2023 Future Owners Bundle Report," has been meticulously assembled to empower U.S AEC Firms with unmatched insights and strategic understanding of firm performance, culture, and productivity.
  • The 2022 Principals, Partners & Owners Report offers detailed compensation analytics and insights into the roles and expectations of the upper echelons in AEC firms.
  • With its unveiling, the "2023 Future Owners Bundle Report" takes a central place among the vital resources for industry leaders tasked with steering their firms towards a prosperous future in the vibrant world of architecture, engineering, and construction.

Publication of Circular and Notice of Requisitioned EGM

Retrieved on: 
Monday, January 8, 2024
Risk, Audit committee, Notice, Requisition, Management, Procedure, CFO, AGM, Form, Dragon (magazine), Dragon, ALL, EGM, Limited, Hand, Chair, UK Corporate Governance Code, Prejudice, Environment, BEST, Sale, Computershare, Circular, Acquisition, Completion

The Notice of Extraordinary General Meeting sets out the resolutions to be proposed at the Requisitioned EGM (the “Vision Resolutions”) and is contained in the Circular.

Key Points: 
  • The Notice of Extraordinary General Meeting sets out the resolutions to be proposed at the Requisitioned EGM (the “Vision Resolutions”) and is contained in the Circular.
  • THE BOARD OF I-RES UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS VOTE AGAINST ALL Vision RESOLUTIONS AT THE REQUISITIONED EGM.
  • Shareholders are also invited to submit their votes in respect of the Vision Resolutions to be put to Shareholders at the Requisitioned EGM through any other means described in the Circular.
  • Details of how to do this are provided in the Statement of Procedures to the Notice of Extraordinary General Meeting set out in the Circular.

Syringes, Needles, and Urinary Catheters Market Forecast to 2033, by Size, Segments, Share, Regulatory, Reimbursement and Procedures - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 27, 2023
Biotechnology, Medical Devices, Health, Health Technology, Medical Supplies, Epidemiology, Urine, Cardiac catheterization, Patient, Procedure, Urinary catheterization, Needle, Market access, Internet, Urinary incontinence, Urinary retention

The "Syringes, Needles, and Urinary Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Syringes, Needles, and Urinary Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.
  • Urinary catheters are used to treat patients with urinary incontinence, urinary retention, or other urological disorders.
  • Urinary catheters include indwelling (Foley) catheter, intermittent (short term) catheter, and external (condom) catheter.
  • Annualized total Syringes, Needles, and Urinary Catheters market revenue by segment and market outlooks from 2015-2033.

Compression Garments and Bandages Market Forecast to 2033, by Size, Segments, Share, Regulatory, Reimbursement and Procedures - ResearchAndMarkets.com

Retrieved on: 
Friday, December 22, 2023
General Health, Health, Medical Supplies, Temple garment, Procedure, SWOT, Lymphedema, Varicose veins, Cancer, Market access, Edema, Vein, Internet, Epidemiology, Pressure, Retail

The "Compression Garments and Bandages Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Compression Garments and Bandages Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.
  • Compression garments are divided into upper and lower compression garments depending on the part of the body they are used for.
  • Compression bandages are used for treating various diseases like deep vein thrombosis, varicose veins, venous leg ulcers and cancer related lymphedema.
  • Annualized total Compression Garments and Bandages market revenue by segment and market outlooks from 2015-2033.